What you need to know about the newborn gut microbiome with Stephanie Culler
Release date: October 26, 2026
The infant gut microbiome supports immune development and may help prevent noncommunicable diseases, yet many infants lack essential microbes. In this episode, Stephanie Culler and I discuss the research, the health effects of this deficit, and Persephone Biosciences, the firm she created to address this issue. More information about Stephanie and Persephone Biosciences is below.
Biography of Stephanie Culler
Stephanie Culler, Ph.D., is the co-founder and CEO of Persephone Biosciences, where she is pioneering microbiome-based medicines to transform human health. She is the lead author of the My Baby Biome study, the largest U.S. study to profile the infant gut microbiome, and her work spans applications from infant health to oncology. Stephanie earned her Ph.D. from the California Institute of Technology and has authored more than 20 scientific publications and patents.
Links
Persephone Biosciences
Comments